Legal Issues

Companies announce co-promotion, manufacturing, settlement agreements

Published in Drug Week, May 13th, 2005

Kos Pharmaceuticals, Inc. (KOSP) and Barr Pharmaceuticals, Inc. (BRL) announced that that they have signed co-promotion, licensing and manufacturing, and settlement and license agreements relating to the resolution of the patent litigation involving Kos' Niaspan products.

The United States District Court for the Southern District of New York entered into a consent dismissal ending the pending litigation between the 2 companies. These arrangements have been established to provide benefits to millions of female patients who have multiple lipid disorders and are candidates for Kos' niacin-based pharmaceutical cholesterol products.

The co-promotion...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2005-05-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry